Heterogeneity of aldehyde dehydrogenase expression in lung cancer cell lines is revealed by Aldefluor flow cytometry‐based assay
Open Access
- 16 November 2006
- journal article
- research article
- Published by Wiley in Cytometry Part B: Clinical Cytometry
- Vol. 72B (4) , 281-289
- https://doi.org/10.1002/cyto.b.20161
Abstract
Background: We have been interested in studying the roles of two aldehyde dehydrogenases in the biology of lung cancer. In this study, we seek to apply Aldefluor flow cytometry‐based assay for the measurement of aldehyde dehydrogenase (ALDH) activity in lung cancer cell lines, which may become a new tool that will facilitate our continued research in this field.Experimental Design: Several established lung cancer cell lines were used, including A549 cell line expressing siRNA against aldehyde dehydrogenase class‐1A1 (ALDH1A1). Western blot analysis, spectrophotometry assay, and Aldefluor staining were used to measure protein or enzyme activity in these cell lines. For the purpose of measurement of ALDH activity by Aldefluor in cells with known high ALDH levels, cells were mixed 1:10 with immortalized lung epithelial cell line (Beas‐2B), which is known to lack ALDH activity. To delineate dead cells, double staining using Aldefluor and propidium iodide (PI) was done. Double staining was also used to detect changes in ALDH activity in two different cell lines after treatment with 4‐hydroperoxycyclophosphamide (4‐HC).Results: Our results show a very good correlation between Aldefluor, Western blot, and spectrophotometry assays. Mixing experiments with Beas‐2B cells allowed accurate assessment of ALDH activity in A549 cells at baseline and after siRNA expression, thus establishing an approach that facilitates the measurement of very high ALDH using the Aldefluor assay. Aldefluor staining was able to detect heterogeneity in ALDH expression among as well as within the same cell lines and better assess viability after 4‐HC treatment when combined with PI.Conclusions: Aldefluor assay can be adapted successfully to measure ALDH activity in lung cancer cells and may have the advantage of providing real time changes in ALDH activity in viable cells treated with siRNA or chemotherapy. © 2006 International Society for Analytical CytologyKeywords
This publication has 21 references indexed in Scilit:
- Characterization of Cells with a High Aldehyde Dehydrogenase Activity from Cord Blood and Acute Myeloid Leukemia SamplesThe International Journal of Cell Cloning, 2005
- Identification of Bronchioalveolar Stem Cells in Normal Lung and Lung CancerCell, 2005
- Aldehyde dehydrogenase activity as a marker for the quality of hematopoietic stem cell transplantsBone Marrow Transplantation, 2005
- Retinoic Acid Down-Regulates Aldehyde Dehydrogenase and Increases Cytotoxicity of 4-Hydroperoxycyclophosphamide and AcetaldehydeThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Phenotypic Characterization of Murine Primitive Hematopoietic Progenitor Cells Isolated on Basis of Aldehyde Dehydrogenase ActivityThe International Journal of Cell Cloning, 2004
- Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activityBlood, 2004
- Distinct functions forAldh1 andRaldh2 in the control of ligand production for embryonic retinoid signaling pathwaysDevelopmental Genetics, 1999
- In VitroSelection for K562 Cells with Higher Retrovirally Mediated Copy Number of Aldehyde Dehydrogenase Class-1 and Higher Resistance to 4-HydroperoxycyclophosphamideHuman Gene Therapy, 1998
- Detoxification of cyclophosphamide by human aldehyde dehydrogenase isozymesCancer Letters, 1994
- Characterization of the state of differentiation of six newly established human non-small-cell lung cancer cell linesDifferentiation, 1988